Generate a tailored SOP for Dr. Gregory Dore. Improve your application with a focused, well-structured draft.
Professor Gregory Dore is a prominent figure in the field of Infectious Diseases, serving as the Head of the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW Sydney. With over 25 years of experience in clinical epidemiological research, he has made significant contributions to public health policy and clinical care relating to viral hepatitis and HIV. He is internationally recognized for his work on the natural history and epidemiology of hepatitis C virus (HCV), as well as developing therapeutic strategies aimed at both acute and chronic HCV infections, particularly within marginalized populations such as people who inject drugs. Professor Dore has been instrumental in establishing leading national and international hepatitis C treatment services and has received substantial public sector research funding from notable organizations, including the U.S. National Institutes of Health and the Australian National Health and Medical Research Council (NHMRC). His leadership roles include serving as President of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, and he is a Fellow of the Australian Academy of Health and Medical Sciences. His research endeavors also focus on strategy development for HCV elimination and addressing the healthcare needs of those experiencing homelessness.
Kirby Institute • Sydney, Australia
Leading research on viral hepatitis and developing treatment strategies.
St Vincent’s Hospital • Sydney, Australia
Clinical care and public health initiatives focused on infectious diseases.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.